Mark G. Hibberd

4.3k total citations
49 papers, 3.4k citations indexed

About

Mark G. Hibberd is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Mark G. Hibberd has authored 49 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 13 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Surgery. Recurrent topics in Mark G. Hibberd's work include Cardiac Imaging and Diagnostics (11 papers), Cardiomyopathy and Myosin Studies (11 papers) and Cardiovascular Function and Risk Factors (8 papers). Mark G. Hibberd is often cited by papers focused on Cardiac Imaging and Diagnostics (11 papers), Cardiomyopathy and Myosin Studies (11 papers) and Cardiovascular Function and Risk Factors (8 papers). Mark G. Hibberd collaborates with scholars based in United States, United Kingdom and Israel. Mark G. Hibberd's co-authors include David R. Trentham, Yale E. Goldman, B. R. Jewell, Jody A. Dantzig, Michael Simons, Michael L. Chuang, Pamela S. Douglas, J. Li, Jessica Grossman and James P. Morgan and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Mark G. Hibberd

47 papers receiving 3.3k citations

Peers

Countries citing papers authored by Mark G. Hibberd

Since Specialization

Citations

This map shows the geographic impact of Mark G. Hibberd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Hibberd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Hibberd more than expected).

Fields of papers citing papers by Mark G. Hibberd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark G. Hibberd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Hibberd. The network helps show where Mark G. Hibberd may publish in the future.

Co-authorship network of co-authors of Mark G. Hibberd

This figure shows the co-authorship network connecting the top 25 collaborators of Mark G. Hibberd. A scholar is included among the top collaborators of Mark G. Hibberd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark G. Hibberd. Mark G. Hibberd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Estimating the rate of acute adverse reactions to non-ionic low-osmolar contrast media: a systematic review and meta-analysis 2025 ·European Radiology ·Yuguo Wei, (unknown), Mark G. Hibberd, (unknown), (unknown)	1
2	Repeat and single dose administration of gadodiamide to rats to investigate concentration and location of gadolinium and the cell ultrastructure 2021 ·Scientific Reports ·Julie Davies, Michael Marino, Adrian Smith, (unknown), Michael Due Larsen, (unknown), (unknown), Mark G. Hibberd, Paul M. Evans	23
3	Population pharmacokinetic–pharmacodynamic modelling of the relationship between testosterone and prostate specific antigen in patients with prostate cancer during treatment with leuprorelin 2019 ·British Journal of Clinical Pharmacology ·(unknown), Henk‐Jan Drenth, (unknown), Nolan Wood, Mark G. Hibberd, Graham Scott	4
4	Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects 2015 ·Clinical and Translational Gastroenterology ·Yuuichi Sakurai, Akira Nishimura, (unknown), Mark G. Hibberd, Richard O. Jenkins, Hiroyuki Okamoto, Tomoki Yoneyama, Helen Jenkins, Kiyoshi Ashida, Shin Irie, Jörg Täubel	141
5	Acute Mortality in Critically Ill Patients Undergoing Echocardiography With or Without an Ultrasound Contrast Agent 2013 ·JACC. Cardiovascular imaging ·Michael L. Main, Mark G. Hibberd, (unknown), Timothy J. Lowe, Paula G. Miller, Gajanan Bhat	46
6	Acute Mortality in Hospitalized Patients Undergoing Echocardiography With and Without an Ultrasound Contrast Agent (Multicenter Registry Results in 4,300,966 Consecutive Patients) 2008 ·The American Journal of Cardiology ·Michael L. Main, (unknown), (unknown), (unknown), Lisa L. Kusnetzky, Mark G. Hibberd	117
7	Relation Between Number of Component Views and Accuracy of Left Ventricular Mass Determined by Three-Dimensional Echocardiography 2007 ·The American Journal of Cardiology ·Michael L. Chuang, Carol J Salton, Mark G. Hibberd, Warren J. Manning, Pamela S. Douglas	7
8	A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous MCC-135 as an Adjunct to Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Rationale and Design of the Evaluation of MCC-135 for Left Ventricular Salvage in Acute MI (EVOLVE) Study 2005 ·Journal of Thrombosis and Thrombolysis ·Ik–Kyung Jang, (unknown), Michael H. Picard, Peter R. Kowey, V. Demmel, Michael R. Zile, Jun Tatsuno, Frans J.Th. Wackers, Mark G. Hibberd	12
9	A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose‐escalation regimen in patients with erectile dysfunction 2002 ·British Journal of Urology ·(unknown), Peter Ströberg, Stan Bukofzer, Nicholas Mallard, Mark G. Hibberd	19
10	Patient motion compensation during transthoracic 3-D echocardiography 2001 ·Ultrasound in Medicine & Biology ·Michael L. Chuang, Mark G. Hibberd, (unknown), (unknown), Marilyn F. Riley, (unknown), Pamela S. Douglas	8
11	Effect of increased body mass index on accuracy of two-dimensional echocardiography for measurement of left ventricular volume, ejection fraction, and mass 2001 ·The American Journal of Cardiology ·Michael L. Chuang, Peter G. Danias, Marilyn F. Riley, Mark G. Hibberd, Warren J. Manning, Pamela S. Douglas	18
12	Importance of imaging method over imaging modality in noninvasive determination of left ventricular volumes and ejection fraction 2000 ·Journal of the American College of Cardiology ·Michael L. Chuang, Mark G. Hibberd, Carol J Salton, (unknown), Marilyn F. Riley, Robert A. Parker, Pamela S. Douglas, Warren J. Manning	190
13	Accuracy of three-dimensional echocardiography with unrestricted selection of imaging planes for measurement of left ventricular volumes and ejection fraction 2000 ·American Heart Journal ·Mark G. Hibberd, Michael L. Chuang, (unknown), Marilyn F. Riley, (unknown), (unknown), Warren J. Manning, Pamela S. Douglas	44
14	Impact of On-Line Endocardial Border Detection on Determination of Left Ventricular Volume and Ejection Fraction by Transthoracic 3-Dimensional Echocardiography 1999 ·Journal of the American Society of Echocardiography ·Michael L. Chuang, (unknown), (unknown), (unknown), Warren J. Manning, Mark G. Hibberd, Pamela S. Douglas	12
15	Relation between the number of image planes and the accuracy of three-dimensional echocardiography for measuring left ventricular volumes and ejection fraction 1998 ·The American Journal of Cardiology ·Peter G. Danias, Michael L. Chuang, Robert A. Parker, (unknown), (unknown), Warren J. Manning, Pamela S. Douglas, Mark G. Hibberd	24
16	Perivascular delivery of prolonged half-life aFGF via EVAC results in angiographic collateral development, improvement in coronary flow and function in chronic myocardial ischemia 1996 ·Journal of the American College of Cardiology ·John J. López, Elazer R. Edelman, (unknown), Kenneth A. Thomas, (unknown), Mark G. Hibberd, Ronald Caputo, Joseph P. Carrozza, Pamela S. Douglas, Frank W. Sellke, Michael Simons	2
17	Magnetic resonance mapping demonstrates benefits of VEGF–induced myocardial angiogenesis 1995 ·Nature Medicine ·Justin D. Pearlman, Mark G. Hibberd, Michael L. Chuang, Kazumasa Harada, John J. López, (unknown), Menahem Friedman, Frank W. Sellke, Michael Simons	258
18	Three-dimensional Echocardiographic Reconstruction of Right Ventricular Volume: In Vitro Comparison With Two-Dimensional Methods 1994 ·Journal of the American Society of Echocardiography ·Leng Jiang, Mark D. Handschumacher, Mark G. Hibberd, Samuel C. Siu, Mary Etta King, Arthur E. Weyman, Robert A. Levine	52
19	Potential impact of pulmonary artery catheter placement on short-term management decisions in the medical intensive care unit 1993 ·American Heart Journal ·(unknown), Mark G. Hibberd, (unknown), Ted W. Love, Daniel S. Ory, Terry S. Field, GW Dec, Kim A. Eagle	6
20	Mitoxantrone combined with vincristine, cyclophosphamide and fluorouracil for advanced breast cancer. A study of short-term response rate. 1987 ·PubMed ·Misset Jl, R Metz, (unknown), R Keiling, P Cappelaere, (unknown), (unknown), (unknown), G Mathé, Mark G. Hibberd	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact